An allelic variant at the ATM locus is implicated in breast cancer susceptibility

Genetic Testing

Volumn 1, Issue 3, 1998, Pages 165-170

  Larson, Garry P ^a   Zhang, Guoxiang ^a   Ding, Shaofeng ^a   Foldenauer, Kimberly ^a   Udar, Nitin ^b   Gatti, Richard A ^c   Neuberg, Donna ^d   Lunetta, Kathryn L ^d   Ruckdeschel, John C ^e   Longmate, Jeffrey ^a   Flanagan, Steven ^a   Krontiris, Theodore G ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MARTES PENNANTI;

ATM PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; ATAXIA TELANGIECTASIA; BREAST TUMOR; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MIDDLE AGED; MUTATION; ONCOGENE RAS; RISK;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; EXONS; FEMALE; GENES, RAS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 0000520601     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.165     Document Type: Article

References (15)

1. ATHMA, P., RAPPAPORT, R., and SWIFT, M. (1996). Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92:130-134.
2. BUFFONE, G.J. (1985). Isolation of DNA from biological specimens without extraction with phenol. Clin. Chem. 31:164-165.
3. FITZGERALD, M.G., BEAN, J.M., HEDGE, S.R., UNSAL, H., MACDONALD, D.J., HARKIN, D.P., and FINKELSTEIN, D.M. (1997). Heterozygous ATM mutations do not contribute to early onset breast cancer. Nature Genet. 15:307-310.
4. KRONTIRIS, T.G., DEVLIN, B., KARP, D.D., ROBERT, N.J., and RISCH, N. (1993). An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. New Eng. J. Med. 329:517-523.
5. LITTELL, R.C., and FOLKS, J.L. (1973). Asymptotic optimality of Fisher's method of combining independent tests II. J. Am. Stat. Assoc. 68:193-194.
6. MORGAN, S.E., LOVLY, C., PANDITA, T.K., SHILOH, Y., and KASTAN, M.B. (1997). Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17:2020-2029.
7. PHELAN, C.M., REBBECK, T.R., WEBER, B.L., DEVILEE, P., RUTTLEDGE, M.H., LYNCH, H.T., LENOIR, G.M., STRATTON, M.R., EASTON, D.F., PONDER, B.A.J., CANNON-ALBRIGHT, L., LARSSON, C., GOLDGAR, D.E., and NAROD, S.A. (1996). Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genet. 12:309-311.
8. RYBERG, D., LINDSTEDT, B.A., ZIENOLDDINY, S., and HAUGEN, A. (1995). A hereditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res. 55:3996-3999.
9. SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., VANAGAITE, L., TAGLE, D.A., SMITH, S., UZIEL, T., SFEZ, S., ASHKENAZI, M., PECKER, I., FRYDMAN, M., HARNIK, R., PATANJALI, S.R., SIMMONS, A., CLINES, G.A., SARTIEL, A., GATTI, R.A., CHESSA, L., SANAL, O., LAVIN, M.F., JASPERS, N.G.J., TAYLOR, A.M.R., ARLETT, C.F., MIKI, T., WEISSMAN, S.M., LOVETT, M., COLLINS, F.S., and SHILOH, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
10. SCULLY, R., CHEN, J., PLUG, A., XIAO, Y., WEAVER, D., FEUNTEUN, J., ASHLEY, T., and LIVINGSTON, D.M. (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
11. SHAFMAN, T., KHANNA, K.K., KEDAR, P., SPRING, K., KOZLOV, S., YEN, T., HOBSON, K., GATEI, M., ZHANG, N., WATTERS, D., EGERTON, M., SHILOH, Y., KHARBANDA, S., KUFE, D., and LAVIN, M.F. (1997). Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387:520-523.
12. SHARAN, S.K., MORIMATSU, M., ALBRECHT, U., LIM, D.-S., REGEL, E., DINH, C., SANDS, A., EICHELE, G., HASTY, P., and BRADLEY, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386:804-810.
13. SWIFT, M., REITNAUER, P.J., MORRELL, D., and CHASE, C.L. (1987). Breast and other cancers in families with ataxia-telangiectasia. New Eng. J. Med. 316:1289-1294.
14. VOŔECHOVSKÝ, I., LUO, L., LINDBLOM, A., NEGRINI, M., WEBSTER, A.D., CROCE, C.M., and HAMMARSTROM, L. (1996a). ATM mutations in cancer families. Cancer Res. 56:4130-4133.
15. VOŔECHOVSKÝ, I., RASIO, D., LUO, L., MONACO, C., HAMMARSTROM, L., WEBSTER, A.D., ZALOUDIK, J., BARBANTI-BRODANI, G., JAMES, M., RUSSO, G., CROCE, C.M., and NEGRINI, M. (1996b). The ATM gene and susceptibility to breast cancer: Analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res. 56:2726-2732.